Evidence map›Paper›PMID 27014251›Full record

ArticleFrontiers in microbiology2016

Carriage of Extended-Spectrum Beta-Lactamase-Plasmids Does Not Reduce Fitness but Enhances Virulence in Some Strains of Pandemic E. coli Lineages.

Katharina Schaufler, Torsten Semmler, Derek J Pickard, María de Toro, Fernando de la Cruz, Lothar H Wieler, Christa Ewers, Sebastian Guenther

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 110 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Applied and environmental microbiology · 2025
    Article
  6. Biofilm · 2025
    Article
  7. A plasmid with theMicrobiology (Reading, England) · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Temperatures above 37°C increase virulence of a convergentFrontiers in cellular and infection microbiology · 2024
    Article
  12. Article
  13. Article
  14. Antibiofilm Activity of Sundew Species against Multidrug-ResistantInternational journal of molecular sciences · 2022
    Article
  15. (Antibiotic-Resistant)Environmental science & technology · 2022
    Article
  16. Article
  17. Article
  18. Highly Virulent and Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Katharina SchauflerVeterinary Faculty, Institute of Microbiology and Epizootics, Freie Universität Berlin Berlin, Germany.
Torsten SemmlerVeterinary Faculty, Institute of Microbiology and Epizootics, Freie Universität BerlinBerlin, Germany; Robert Koch InstituteBerlin, Germany.
Derek J PickardWellcome Trust Sanger Institute Cambridge, UK.
María de ToroDepartamento de Biología Molecular, Instituto de Biomedicina y Biotecnología de Cantabria (UC-SODERCAN-CSIC), Universidad de Cantabria Santander, Spain.
Fernando de la CruzDepartamento de Biología Molecular, Instituto de Biomedicina y Biotecnología de Cantabria (UC-SODERCAN-CSIC), Universidad de Cantabria Santander, Spain.
Lothar H WielerVeterinary Faculty, Institute of Microbiology and Epizootics, Freie Universität BerlinBerlin, Germany; Robert Koch InstituteBerlin, Germany.
Christa EwersVeterinary Faculty, Institute of Hygiene and Infectious Diseases of Animals, Justus-Liebig-Universität Giessen Giessen, Germany.
Sebastian GuentherVeterinary Faculty, Institute of Microbiology and Epizootics, Freie Universität Berlin Berlin, Germany.
Freie Universität Berlin · DEUniversidad de Cantabria · ESRobert Koch Institute · DEUniversity of Giessen · DEWellcome Sanger Institute · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Pathogenic ESBL-producing E. coli lineages occur frequently worldwide, not only in a human health context but in animals and the environment, also in settings with low antimicrobial pressures. This study investigated the fitness costs of ESBL-plasmids and their influence on chromosomally encoded features associated with virulence, such as those involved in the planktonic and sessile behaviors of ST131 and ST648 E. coli. ESBL-plasmid-carrying wild-type E. coli strains, their corresponding ESBL-plasmid-"cured" variants (PCV), and complementary ESBL-carrying transformants were comparatively analyzed using growth curves, Omnilog® phenotype microarray (PM) assays, macrocolony and biofilm formation, swimming motility, and RNA sequence analysis. Growth curves and PM results pointed toward similar growth and metabolic behaviors among the strains. Phenotypic differences in some strains were detected, including enhanced curli fimbriae and/or cellulose production as well as a reduced swimming capacity of some ESBL-carrying strains, as compared to their respective PCVs. RNA sequencing mostly confirmed the phenotypic results, suggesting that the chromosomally encoded csgD pathway is a key factor involved. These results contradict the hypothesis that ESBL-plasmid-carriage leads to a fitness loss in ESBL-carrying strains. Instead, the results indicate an influence of some ESBL-plasmids on chromosomally encoded features associated with virulence in some E. coli strains. In conclusion, apart from antibiotic resistance selective advantages, ESBL-plasmid-carriage may also lead to enhanced virulence or adaption to specific habitats in some strains of pandemic ESBL-producing E. coli lineages.

Indexed as

biofilm formationenhanced virulenceESBL-plasmidsESBL-producing E. colifitness costsplasmid and host interaction

Identifiers

PMID27014251
PMCPMC4794485
OpenAlexW2298346855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.